Landscape Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$593K Sell
6,875
-15,819
-70% -$1.41M 0.04% 393
2026
Q2
$2.05M Buy
+22,694
New +$1.9M 0.13% 253
2022
Q1
– Sell
-4,665
Closed -$604K – 933
2021
Q4
$604K Buy
+4,665
New +$544K 0.09% 176
2021
Q3
– Sell
-33,492
Closed -$3.47M – 775
2021
Q2
$3.47M Sell
33,492
-4,286
-11% -$404K 0.42% 63
2021
Q1
$3.16M Buy
+37,778
New +$3.19M 0.5% 49
2019
Q4
– Sell
-109,635
Closed -$8.04M – 687
2019
Q3
$8.04M Buy
109,635
+45,084
+70% +$3.17M 0.59% 32
2019
Q2
$3.98M Buy
64,551
+50,679
+365% +$3.06M 0.32% 75
2019
Q1
$885K Sell
13,872
-729
-5% -$41.6K 0.08% 278
2018
Q4
$745K Sell
14,601
-4,791
-25% -$242K 0.06% 340
2018
Q3
$1.12M Buy
+19,392
New +$948K 0.08% 227
2017
Q4
– Sell
-25,857
Closed -$942K – 670
2017
Q3
$942K Buy
+25,857
New +$986K 0.09% 211
2014
Q4
– Sell
-13,200
Closed -$225K – 540
2014
Q3
$225K Buy
+13,200
New +$208K 0.15% 210

Other funds holding EW

Landscape Capital Management's EW Position: Q3 2026 in Review

Landscape Capital Management reduced its Edwards Lifesciences (EW) stake by 70% in Q3 2026, selling an estimated $1.41M and leaving 6,875 shares worth $593K. The position accounts for 0.04% of the portfolio, ranked #393.

Landscape Capital Management first reported a position in EW in Q3 2014 and has held it in 12 quarters since. The position peaked at $8.04M in Q3 2019. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Landscape Capital Management held 6,875 shares of Edwards Lifesciences worth $593K as of Q3 2026.
  • Landscape Capital Management sold 15,819 Edwards Lifesciences shares in Q3 2026, an estimated $1.41M.
  • Edwards Lifesciences made up 0.04% of Landscape Capital Management's portfolio in Q3 2026, its #393 holding.
  • Landscape Capital Management first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 12 quarters since.
  • Landscape Capital Management's Edwards Lifesciences position peaked at $8.04M in Q3 2019.
  • 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Landscape Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.